These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 35174386

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    ESC Heart Fail; 2021 Dec; 8(6):5142-5148. PubMed ID: 34480414
    [Abstract] [Full Text] [Related]

  • 25. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 26. Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death.
    Weth C, Abuazab H, Ewen S, Ukena C, Böhm M, Custodis F.
    Herzschrittmacherther Elektrophysiol; 2022 Mar; 33(1):55-62. PubMed ID: 34694459
    [Abstract] [Full Text] [Related]

  • 27. A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
    Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, Mathews K, Thakkar AB, Ullery S, Eapen ZJ, Kumar UN, Mehran R, Butler J, Jewel IDE Study Investigators.
    J Am Coll Cardiol; 2024 Aug 06; 84(6):525-536. PubMed ID: 39084827
    [Abstract] [Full Text] [Related]

  • 28. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Klein N, Shin DI, Hijazi M, Rosenkaimer S, Beiert T, Abumayyaleh M, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Aweimer A, Akin I.
    Eur J Clin Invest; 2023 Jul 06; 53(7):e13977. PubMed ID: 36852491
    [Abstract] [Full Text] [Related]

  • 29. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 06; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 30. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 06; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 31. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry.
    Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354
    [Abstract] [Full Text] [Related]

  • 32. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry.
    Odeneg T, Ebner C, Mörtl D, Keller H, Dirninger A, Stix G, Föger B, Grimm G, Steinwender C, Gebetsberger F, Stühlinger M, Mastnak B, Haider C, Manninger M, Scherr D.
    Eur J Cardiovasc Nurs; 2019 Jan 21; 18(1):75-83. PubMed ID: 30064269
    [Abstract] [Full Text] [Related]

  • 33. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A, Guha M, Noutsias M, Klein HH, Klein HU.
    Herz; 2019 Aug 21; 44(5):379-389. PubMed ID: 29234842
    [Abstract] [Full Text] [Related]

  • 34. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    Gassanov N, Mutallimov M, Caglayan E, Erdmann E, Er F.
    J Cardiol; 2022 Dec 21; 80(6):573-577. PubMed ID: 35985868
    [Abstract] [Full Text] [Related]

  • 35. Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    Sensors (Basel); 2022 Mar 05; 22(5):. PubMed ID: 35271182
    [Abstract] [Full Text] [Related]

  • 36. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Arena G, Curnis A, Forleo G, Guerra F, Porcu M, Sgarito G, Botto GL.
    Clin Cardiol; 2021 Nov 05; 44(11):1497-1505. PubMed ID: 34427926
    [Abstract] [Full Text] [Related]

  • 37. Avoiding implantation of a cardioverter-defibrillator by bridging with wearable defibrillator vest.
    Klein N, Kuntz T, Dhein S.
    Herz; 2021 Mar 05; 46(2):172-177. PubMed ID: 31555894
    [Abstract] [Full Text] [Related]

  • 38. Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention.
    Barraud J, Pinon P, Laine M, Cautela J, Orabona M, Koutbi L, Pinto J, Thuny F, Franceschi F, Paganelli F, Bonello L, Peyrol M.
    Heart Lung Circ; 2018 Aug 05; 27(8):984-988. PubMed ID: 28969980
    [Abstract] [Full Text] [Related]

  • 39. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D.
    Heart Vessels; 2018 Nov 05; 33(11):1390-1402. PubMed ID: 29721674
    [Abstract] [Full Text] [Related]

  • 40. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C.
    Eur J Heart Fail; 2014 Dec 05; 16(12):1331-6. PubMed ID: 25371320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.